You have 9 free searches left this month | for more free features.

Blood Stem Cell Transplantation

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)

Active, not recruiting
  • Plasma Cell Myeloma
  • Omaha, Nebraska
    University of Nebraska Medical Center
Nov 21, 2022

Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

Active, not recruiting
  • Chronic Granulomatous Disease Transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute

Not yet recruiting
  • Peripheral Blood Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

Active, not recruiting
  • Leukemia
  • +3 more
  • Palifermin
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

Active, not recruiting
  • Refractory Non Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • rituximab
  • +7 more
  • Sacramento, California
    University of California Davis
Nov 28, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Aachen, NRW, Germany
  • +2 more
Mar 29, 2023

Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

Completed
  • Leukemia
  • +2 more
  • CliniMACS Fractionation system (Arm A)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 12, 2022

Myeloid Chimerism Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (CliniMACS CD34 Reagent)

Recruiting
  • Myeloid Chimerism
  • CliniMACS CD34 Reagent
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 7, 2022

Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
Jan 26, 2023

Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

Recruiting
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 25, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Hematological Malignancy Trial in Detroit (Bortezomib)

Recruiting
  • Hematological Malignancy
  • Detroit, Michigan
    Henry Ford hospital
Dec 23, 2021

Blood Virome After Haploidentical Hematopoietic Stem Cell

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
    • Geneva, Switzerland
      Geneva University Hospitals
    Nov 21, 2022

    Acute Leukemia Trial in Tianjin (Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation,

    Recruiting
    • Acute Leukemia
    • Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation
    • haploidentical hematopoietic stem cell transplantation
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Aug 9, 2022

    Peripheral Blood Stem Cell Transplantation Trial in Beijing (Modified By/Cy conditioning regimen intensified by Ruxolitinib and

    Recruiting
    • Peripheral Blood Stem Cell Transplantation
    • Modified By/Cy conditioning regimen intensified by Ruxolitinib and Chidamide
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Dec 12, 2021

    Breast Cancer Trial in Duarte (biological, drug, procedure)

    Active, not recruiting
    • Breast Cancer
    • filgrastim
    • +10 more
    • Duarte, California
      City of Hope Comprehensive Cancer Center
    Feb 17, 2022

    Precision Medicine for Stem Cell Transplantation

    Not yet recruiting
    • Haematopoietic Stem Cell Transplantation
    • Blood sample collection
    • Bone marrow aspirate
    • (no location specified)
    Oct 4, 2022

    Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

    Terminated
    • Acute Biphenotypic Leukemia
    • +29 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 4, 2023

    Hematologic Malignancies Trial in Milwaukee (CliniMACs)

    Active, not recruiting
    • Hematologic Malignancies
    • CliniMACs
    • Milwaukee, Wisconsin
      Children's Hospital of Wisconsin
    Apr 4, 2022

    Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in

    Active, not recruiting
    • Hematopoietic Cell Transplantation Recipient
    • +3 more
    • Allogeneic Bone Marrow Transplantation
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

    Recruiting
    • Plasma Cell Myeloma
    • Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 27, 2022